243 related articles for article (PubMed ID: 25960228)
1. CD26 a cancer stem cell marker and therapeutic target.
Davies S; Beckenkamp A; Buffon A
Biomed Pharmacother; 2015 Apr; 71():135-8. PubMed ID: 25960228
[TBL] [Abstract][Full Text] [Related]
2. Characterization of cancer stem cell properties of CD24 and CD26-positive human malignant mesothelioma cells.
Yamazaki H; Naito M; Ghani FI; Dang NH; Iwata S; Morimoto C
Biochem Biophys Res Commun; 2012 Mar; 419(3):529-36. PubMed ID: 22369943
[TBL] [Abstract][Full Text] [Related]
3. CD90 a potential cancer stem cell marker and a therapeutic target.
Shaikh MV; Kala M; Nivsarkar M
Cancer Biomark; 2016; 16(3):301-7. PubMed ID: 27062695
[TBL] [Abstract][Full Text] [Related]
4. Identification of cancer stem cell markers in human malignant mesothelioma cells.
Ghani FI; Yamazaki H; Iwata S; Okamoto T; Aoe K; Okabe K; Mimura Y; Fujimoto N; Kishimoto T; Yamada T; Xu CW; Morimoto C
Biochem Biophys Res Commun; 2011 Jan; 404(2):735-42. PubMed ID: 21163253
[TBL] [Abstract][Full Text] [Related]
5. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer.
Pang R; Law WL; Chu AC; Poon JT; Lam CS; Chow AK; Ng L; Cheung LW; Lan XR; Lan HY; Tan VP; Yau TC; Poon RT; Wong BC
Cell Stem Cell; 2010 Jun; 6(6):603-15. PubMed ID: 20569697
[TBL] [Abstract][Full Text] [Related]
6. Emergence of CD26+ Cancer Stem Cells with Metastatic Properties in Colorectal Carcinogenesis.
Cheung AH; Iyer DN; Lam CS; Ng L; Wong SKM; Lee HS; Wan T; Man J; Chow AKM; Poon RT; Pang R; Law WL
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28545226
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
Ricardo S; Vieira AF; Gerhard R; Leitão D; Pinto R; Cameselle-Teijeiro JF; Milanezi F; Schmitt F; Paredes J
J Clin Pathol; 2011 Nov; 64(11):937-46. PubMed ID: 21680574
[TBL] [Abstract][Full Text] [Related]
8. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types.
de Beça FF; Caetano P; Gerhard R; Alvarenga CA; Gomes M; Paredes J; Schmitt F
J Clin Pathol; 2013 Mar; 66(3):187-91. PubMed ID: 23112116
[TBL] [Abstract][Full Text] [Related]
10. Liver cancer stem cell markers: Progression and therapeutic implications.
Sun JH; Luo Q; Liu LL; Song GB
World J Gastroenterol; 2016 Apr; 22(13):3547-57. PubMed ID: 27053846
[TBL] [Abstract][Full Text] [Related]
11. The Identifications and Clinical Implications of Cancer Stem Cells in Colorectal Cancer.
Wahab SMR; Islam F; Gopalan V; Lam AK
Clin Colorectal Cancer; 2017 Jun; 16(2):93-102. PubMed ID: 28237538
[TBL] [Abstract][Full Text] [Related]
12. Cancer stem cell markers: premises and prospects.
Murar M; Vaidya A
Biomark Med; 2015; 9(12):1331-42. PubMed ID: 26612591
[TBL] [Abstract][Full Text] [Related]
13. Molecular Radiotherapy with
Huang T; Lee JS; Klibanov AL; He J
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409274
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem cells (CSCs), cervical CSCs and targeted therapies.
Huang R; Rofstad EK
Oncotarget; 2017 May; 8(21):35351-35367. PubMed ID: 27343550
[TBL] [Abstract][Full Text] [Related]
15. Proteomics of cancer stem cells.
Skvortsov S; Debbage P; Skvortsova I
Int J Radiat Biol; 2014 Aug; 90(8):653-8. PubMed ID: 24350919
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cell marker glycosylation: Nature, function and significance.
Mallard BW; Tiralongo J
Glycoconj J; 2017 Aug; 34(4):441-452. PubMed ID: 28624993
[TBL] [Abstract][Full Text] [Related]
17. Lung cancer stem cells and implications for future therapeutics.
Wang J; Li ZH; White J; Zhang LB
Cell Biochem Biophys; 2014 Jul; 69(3):389-98. PubMed ID: 24549856
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer stem cells: features and detection methods.
Ishiwata T; Matsuda Y; Yoshimura H; Sasaki N; Ishiwata S; Ishikawa N; Takubo K; Arai T; Aida J
Pathol Oncol Res; 2018 Oct; 24(4):797-805. PubMed ID: 29948612
[TBL] [Abstract][Full Text] [Related]
19. Implications of stemness-related signaling pathways in breast cancer response to therapy.
Angeloni V; Tiberio P; Appierto V; Daidone MG
Semin Cancer Biol; 2015 Apr; 31():43-51. PubMed ID: 25153354
[TBL] [Abstract][Full Text] [Related]
20. Targeting cancer stem cells by using the nanoparticles.
Hong IS; Jang GB; Lee HY; Nam JS
Int J Nanomedicine; 2015; 10(Spec Iss):251-60. PubMed ID: 26425092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]